Malygin A, Redjko A, Pogodina O, Karaseva N, Koval Y, Timonen T
Cancer Immunol Immunother. 1993; 36(1):61-4.
PMID: 8422669
PMC: 11038310.
DOI: 10.1007/BF01789133.
Yunis E, Salazar M
Genetica. 1993; 91(1-3):211-23.
PMID: 8125271
DOI: 10.1007/BF01435999.
Andersen B, Kiecolt-Glaser J, Glaser R
Am Psychol. 1994; 49(5):389-404.
PMID: 8024167
PMC: 2719972.
DOI: 10.1037//0003-066x.49.5.389.
Auer I, Ziemer E, Sommer H
Clin Exp Immunol. 1980; 42(1):41-9.
PMID: 7460390
PMC: 1537072.
McCredie J, MacDonald H
Br J Cancer. 1980; 41(6):880-5.
PMID: 7426312
PMC: 2010334.
DOI: 10.1038/bjc.1980.164.
Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity.
Pross H, Baines M, Rubin P, Shragge P, Patterson M
J Clin Immunol. 1981; 1(1):51-63.
PMID: 7334070
DOI: 10.1007/BF00915477.
Suppressed natural killer cell activity during episodes of erythema nodosum leprosum in lepromatous leprosy.
Humphres R, GELBER R, Krahenbuhl J
Clin Exp Immunol. 1982; 49(3):500-8.
PMID: 7172493
PMC: 1536721.
Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease.
White D, Jones D, Cooke T, Kirkham N
Br J Cancer. 1982; 46(4):611-6.
PMID: 7138766
PMC: 2011176.
DOI: 10.1038/bjc.1982.245.
Prognostic significance of immunological tests in lung cancer.
Check I, Hunter R, Karrison T, DeMeester T, Golomb H, Vardiman J
Clin Exp Immunol. 1981; 43(2):362-9.
PMID: 7023761
PMC: 1537274.
Studies of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity among patients with acute leukemia in complete remission.
Talpaz M, Bielski M, Hersh E
Cancer Immunol Immunother. 1982; 14(2):96-8.
PMID: 6965233
PMC: 11039062.
DOI: 10.1007/BF00200175.
Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma.
Liberati A, Voelkel J, Borden E, Coates A, Citrin D, Bryan G
Cancer Immunol Immunother. 1982; 13(2):140-4.
PMID: 6961952
PMC: 11039203.
DOI: 10.1007/BF00205315.
Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients.
Balch C, Tilden A, Dougherty P, Cloud G
Ann Surg. 1983; 198(2):192-9.
PMID: 6870377
PMC: 1353079.
DOI: 10.1097/00000658-198308000-00014.
Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer.
Fulton A, Heppner G, Roi L, Howard L, Russo J, Brennan M
Breast Cancer Res Treat. 1984; 4(2):109-16.
PMID: 6743837
DOI: 10.1007/BF01806393.
Enhanced K-cell activity in the peripheral blood of patients with malignant disease.
Bakacs T, CZANIK P, Kimber I, Ringwald G, Moore M, Abraham E
Cancer Immunol Immunother. 1984; 16(3):170-4.
PMID: 6561069
PMC: 11039235.
DOI: 10.1007/BF00205424.
Natural cell-mediated cytotoxicity in normal human peripheral blood lymphocytes and its in vitro boosting with BCG.
Mandeville R, Sombo F, Rocheleau N
Cancer Immunol Immunother. 1983; 15(1):17-22.
PMID: 6553503
PMC: 11039096.
DOI: 10.1007/BF00199456.
Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas.
Funa K, Nilsson B, Jacobsson G, Alm G
Br J Cancer. 1984; 50(2):231-3.
PMID: 6466540
PMC: 1976881.
DOI: 10.1038/bjc.1984.168.
Twenty-fifth annual general meeting of the British Association for Cancer Research. Abstracts of invited and profferred papers.
Br J Cancer. 1984; 50(2):239-78.
PMID: 6380555
PMC: 1976880.
DOI: 10.1038/bjc.1984.170.
Natural killer cells: artifact to reality: an odyssey in biology.
Oldham R
Cancer Metastasis Rev. 1983; 2(4):323-36.
PMID: 6375859
DOI: 10.1007/BF00048565.
The biology of the human natural killer cell.
Roder J, Pross H
J Clin Immunol. 1982; 2(4):249-63.
PMID: 6292259
DOI: 10.1007/BF00915064.
Natural killer cells in human solid tumors.
Introna M, Mantovani A
Cancer Metastasis Rev. 1983; 2(4):337-50.
PMID: 6203638
DOI: 10.1007/BF00048566.